NDC 50090-6532-01 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6532
- Requested NDC
- 50090-6532-01
- Package NDCs from labels
- 50090-6532-0, 50090-6532-1, 50090-6532-8, 50090-6532-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-06-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2023-06-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6532-0 | Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 50090-6532-1 | Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 50090-6532-8 | Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6532 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 3 package rows | 20230630_b56a3559-6eb2-4a8d-a9a4-232d2ff0febe.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6532-0 | EA - Each | 50090-6532 | 305f73b3-bef6-4502-acdf-0d22c2e16060 | 1 | 2023-08-08 |
| 50090-6532-1 | EA - Each | 50090-6532 | 16bda394-a4bc-40a3-952d-616a27a616ae | 1 | 2023-08-08 |
| 50090-6532-8 | EA - Each | 50090-6532 | 73735477-5b2b-445b-9e22-2a453167b0f8 | 1 | 2023-08-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 2fd8f595-7aec-4308-bb17-a6f2e7190044 | 2026-04-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | ff557069-f177-4e2e-91f4-675a033e2739 | 2026-04-14 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 2c8bb018-af07-4745-a4e9-f9a6795a5ea2 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 03c0ec8d-9daf-43e8-8a4e-a2ddc3573ca7 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | American Health Packaging | c8de63da-b6c0-42f0-9d47-e273fe93adb3 | 2026-04-07 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Coupler LLC | 4ee35bcf-1eb0-1cca-e063-6294a90adeed | 2026-04-07 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5029c9f7-6233-4a6f-ace9-2268cc8e286d | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 019ac336-0dc3-ec89-3e0a-09110e0fc30b | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | eac8c44f-cf77-6a30-cfd7-7cffffc79bd6 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | be99cc03-ea65-4b17-bd9e-df7ae4307778 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Accord Healthcare Inc. | babb1b20-fe82-40ba-8e7a-0c56fe433b4a | 2026-04-01 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | 72fa8cd4-bc2a-4a7d-8feb-2d60e077d801 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 45316037-52ec-438f-8780-b2e983fef3f5 | 2026-03-31 | Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b3228678-7992-4148-b4ab-aa0d8b1b8570 | 2026-03-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | c2db7e27-952f-c3f6-e053-2995a90af7c1 | 2026-03-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 59801c48-2af7-4967-ae70-99f865551a7a | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | c2d993ff-b11b-7a62-e053-2995a90a0b00 | 2026-03-25 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 1d6712a3-bfb3-4081-b8f6-6057eb4baa27 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 53ce6e4f-db3a-4789-8bef-1e459fa78b79 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 905568ae-ce27-4978-90c7-b5c93279ecd1 | 2026-03-12 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.